Insiders · Profile

Moss David J

Chief Financial Officer at Inmune Bio · PRES, CEO, TRES, CFO, SECR at Tonix Pharmaceuticals. Filing since 5 May 2011. CIK 0001421930

Company
Date
Role
Action
Shares
Amount
Of holding
30 Sep 2024
Chief Financial Officer
Bought
10,000
$52.87K
0.8%
12 Sep 2024
Chief Financial Officer
Bought
7,690
$49.02K
0.6%
17 Mar 2023
CFO, Treasurer & Secretary
Bought
2,500
$16.06K
0.2%
27 May 2022
CFO, Treasurer & Secretary
Bought
3,000
$20.37K
0.2%
26 May 2022
CFO, Treasurer & Secretary
Bought
7,700
$48.28K
0.6%
3 Nov 2021
CFO, Treasurer & Secretary
Sold, plan not stated
1,025
$20.50K
0.1%
27 Oct 2021
CFO, Treasurer & Secretary
Sold, plan not stated
2,079
$41.58K
0.2%
25 Oct 2021
CFO, Treasurer & Secretary
Sold, plan not stated
13
$260.00
0.0%
22 Oct 2021
CFO, Treasurer & Secretary
Sold, plan not stated
1,142
$22.84K
0.1%
8 Jul 2021
CFO, Treasurer & Secretary
Sold, plan not stated
16,302
$327.49K
1.3%
7 Jul 2021
CFO, Treasurer & Secretary
Sold, plan not stated
8,698
$174.03K
0.7%
20 Aug 2019
CFO, Treasurer & Secretary
Bought
3,000
$16.95K
0.2%
3 Jun 2019
CFO, Treasurer & Secretary
Bought
10,000
$60.00K
0.8%
6 May 2019
CFO, Treasurer & Secretary
Bought
5,000
$45.00K
0.4%
5 May 2011
PRES, CEO, TRES, CFO, SECR
Bought
250,000
$10.00K
8.3%
15 decisions on file.